LEADER 03457nam  2200649 a 450 
001 9910840899903321
005 20230421044618.0
010   $a1-282-13792-1
010   $a9786612137921
010   $a0-470-51467-1
010   $a0-470-51468-X
035   $a(CKB)1000000000377313
035   $a(EBL)470529
035   $a(SSID)ssj0000367260
035   $a(PQKBManifestationID)11252344
035   $a(PQKBTitleCode)TC0000367260
035   $a(PQKBWorkID)10418510
035   $a(PQKB)11263840
035   $a(MiAaPQ)EBC470529
035   $a(OCoLC)181177712
035   $a(EXLCZ)991000000000377313
100   $a19940802d1994      uy         0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 00$aVaccines against virally induced cancers$b[electronic resource]
210   $aChichester ;$aNew York $cJ. Wiley$d1994
215   $a1 online resource (293 p.)
225 1 $aCiba Foundation symposium ;$v187
300   $a"Ciba Foundation"--Cover.
300   $aSymposium held at the Ciba Foundation, London, 15-17 March 1994, based on a proposal by Ian Frazer.
311   $a0-471-95026-2 
320   $aIncludes bibliographical references and indexes.
327   $aVACC I N ES AGAl NST VIRALLY INDUCED CANCERS; Contents; Participants; Introdu ction; Potential antigenic targets on Epstein - Bar r vir us-associated tumours and the host response; The host response to lesions induced by human papillomavirus; General discussion I; Human T cell lymphotropic virus: necessity for and feasibility of a vaccine; Vaccination against cutaneous and mucosal papillomavirus in cattle; Strategies for studying mouse and human immune responses to human papillomavirus type 16
327   $aProspects for T cell immunotherapy of tumours by vaccination with immunodominant and su bdominant peptidesHepatitis B virus infection, the immune response and hepatocellular carcinoma; The role of superantigens in the immunobiology of retroviruses; General discussion I I; Assembly and transport of class I MHC-peptide complexes; Induction and regulation of CD4+ T cell subsets; Propagation of mouse and human T cells with defined antigen specificity and function; Immunity to the HER-2heu oncogenic protein
327   $aGenetic modification of T cell clones to improve the safety and efficacy of adoptive T cell therapyBone marrow-derived cells present MHC class I-restricted tumour antigens in priming of antiturnour immune responses; Evasion of host immune responses by tumours and viruses; Final dscussion; Index of contributors; Subject index
330   $aAn interdisciplinary and multinational group of specialists present contributions describing the current status of vaccines against virally induced tumors and discuss the means by which they can be improved.
410  0$aCiba Foundation symposium ;$v187.
606   $aViral carcinogenesis$vCongresses
606   $aViral vaccines$vCongresses
606   $aCancer$xImmunotherapy$vCongresses
615  0$aViral carcinogenesis
615  0$aViral vaccines
615  0$aCancer$xImmunotherapy
676   $a616.99
676   $a616.992061
701   $aFrazer$b I. H$g(Ian H.)$01728369
712 02$aCiba Foundation.
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910840899903321
996   $aVaccines against virally induced cancers$94136912
997   $aUNINA